Skip to main content

Using PML nuclear body biology to identify potential AML treatment targets

Project description

Understanding PML nuclear bodies disruption in the context of AML treatment

Call for proposal

H2020-MSCA-IF-2018
See other projects for this call

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
Address
Rue De Tolbiac 101
75654 Paris
France
Activity type
Research Organisations
EU contribution
€ 184 707,84